Odyssey Health (ODYY) Notes Payables (2022 - 2026)

Odyssey Health (ODYY) posted quarterly Notes Payables of $100000.0 for Q2 2026, down 97.46% quarter-over-quarter from $3.9 million in Q1 2026.

Odyssey Health (ODYY) Notes Payables (2022 - 2026) Analysis & Trends

Odyssey Health's Notes Payables history runs 4 years deep, the most recent figure standing at $100000.0 for Q2 2026.

In Q2 2026, Notes Payables changed N/A year-over-year to $100000.0; the TTM figure through Apr 2026 stood at $100000.0 (changed N/A YoY), while the FY2025 annual figure was $100000.0, changed N/A from the prior year.
Notes Payables for Q2 2026 stood at $100000.0, down from $3.9 million in the prior quarter.
The five-year high for Notes Payables was $3.9 million in Q1 2026, with the low at $100000.0 in Q3 2025.
The 4-year median for Notes Payables is $125000.0 (2022), against an average of $658738.0.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn
10	Odyssey Health	1.01 Mn	711,880.61	-

Download Data